![Daniel Apel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Apel
Finanzdirektor/CFO bei
ARROWHEAD PHARMACEUTICALS, INC.
Vermögen: 14 Mio $ am 30.06.2026
Profil
Daniel J.
Apel is currently Director at Conceptus, Inc. since 2013, Director at Biotechnology Innovation Organization, and Chief Financial Officer at Arrowhead Pharmaceuticals, Inc. starting in 2025.
Formerly, Mr. Apel was Chief Financial Officer at Bayer Corp.
from 2016 to 2019 and Global Head-Financial Planning & Analysis at Walgreens Boots Alliance, Inc. from 2019 to 2024.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.01.2026 | 176.200 ( 0,13 % ) | 14 Mio $ | 30.06.2026 |
Aktive Positionen von Daniel Apel
| Unternehmen | Position | Beginn |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 13.05.2025 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
Conceptus, Inc.
 Conceptus, Inc. Medical SpecialtiesHealth Technology Develops and markets minimally invasive devices for reproductive medical applications | Direktor/Vorstandsmitglied | 05.06.2013 |
Ehemalige bekannte Positionen von Daniel Apel
| Unternehmen | Position | Ende |
|---|---|---|
| WALGREENS BOOTS ALLIANCE, INC. | Corporate Officer/Principal | 01.01.2024 |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Finanzdirektor/CFO | 01.01.2019 |
Ausbildung von Daniel Apel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Conceptus, Inc.
Conceptus, Inc. Medical SpecialtiesHealth Technology Develops and markets minimally invasive devices for reproductive medical applications | Health Technology |
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Walgreens Boots Alliance, Inc.
 Walgreens Boots Alliance, Inc. Drugstore ChainsRetail Trade Retails and wholesales pharmaceuticals & provides technology-enabled healthcare services | Retail Trade |
